Notable Labs Gross Profit

Notable Labs posts a gross profit of $1K as of June 2024. That is below the Healthcare sector average of $66B. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

For Healthcare stocks, a gross profit near $66B is typical. Notable Labs's $1K is lower that level. That is roughly 100.0% below the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.

Gross Profit is one piece of Notable Labs's financial statement story. At $1K, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for NTBL's gross profit usually means three checks: (1) trend versus prior periods, (2) level versus peers (average $66B), and (3) consistency with growth and profitability. This page covers the first two; Notable Labs's other metric pages and overview cover the third.

Judging Notable Labs against Healthcare peers is usually better than using a market-wide rule of thumb. Business models inside Healthcare are more comparable, which makes gaps in gross profit easier to interpret. Start with $1K here, then scan peer and history charts to see if the gap is persistent.